Media

News and press releases

Welcome to our media section. Check out the latest news and press releases from Cinclus Pharma and don’t hesitate to contact us if you need more information.

Media gallery

Charlotte Stjerngren

Press and IR

E-mail: Send e-mail

Phone: +46 708 768 787

Latest pressreleases

See all Subscribe

Latest News

Watch the presentation from Redeye Investor Forum October 10th

2024-10-11

Here, you can watch the full presentation (in Swedish) by CEO of Cinclus Pharma, Christer Ahlberg, from Redeye AB Investor Forum October 10th, on the company and the development of linaprazan glurate.

Cinclus Pharma at Redeye Investor Forum in Gothenburg

2024-09-30

Cinclus Pharma participates at Redeye Investor Forum in Gothenburg October 10th. Christer Ahlberg, CEO of Cinclus Pharma, will present the company and the development of linaprazan glurate.

Cinclus Pharma's CEO Christer Ahlberg interviewed by Redeye

2024-09-25

Cinclus Pharma's CEO Christer Ahlberg was interviewed by Okee Williams at Redeye AB on September 23, about the company and the development of the drug candidate linaprazan glurate.

Watch the presentation from Redeye Investor Forum Online September 19th

2024-09-20

Christer Ahlberg, CEO of Cinclus Pharma, was invited to present the company's latest updates and the development of linaprazan glurate at the Redeye Investor Forum Online on September 19th, 2024.

See all News

Cinclus Pharma in media

Cinclus Pharma's CEO Christer Ahlberg interviewed by Redeye

2024-09-23

Cinclus Pharma's CEO Christer Ahlberg was interviewed by Okee Williams at Redeye AB on September 23, about the company and the development of the drug candidate linaprazan glurate.

Interview with Christer Ahlberg, CEO of Cinclus Pharma, in Börspodden

2024-06-26

Christer Ahlberg, participated in Börspodden to talk about the listing and the upcoming plans for the company. Listen to the interview at 00:43:25 (in Swedish).